L. Boer

发表

CHAPTER 6 3 V \ FKRVRFLDO FRJQLWLYH DQG PRWRU IXQFWLRQLQJ LQ SDWLHQWV VXVSHFWHG RI 6 RWRV V \ QGURPH $ FRPSDULVRQ EHWZHHQ SDWLHQWV ZLWK 16 ' JHQH DOWHUDWLRQV DQG SDWLHQWV ZLWKRXW

J. Wit, L. Boer, I. Röder, 2005 .

CHAPTER 2 * HQRW \ SH SKHQRW \ SH FRUUHODWLRQ LQ SDWLHQWV VXVSHFWHG RI KDYLQJ 6 RWRV V \ QGURPH

S. Cessie, R. Hennekam, J. Wit, 2006 .

Auxological data in patients clinically suspected of Sotos syndrome with NSD1 gene alterations

S. Cessie, J. Wit, L. Boer, 2005 .

Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations

J. Wit, L. Boer, I. Röder, 2006 .

Hereditary Dizygotic Twins Increased Levels and Pulsatility of Follicle-Stimulating Hormone in Mothers of Society

D. Boomsma, C. Lambalk, E. Schoute, 1998 .

High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders

R. Rodenburg, S. Wortmann, J. Smeitink, 2015, Journal of Inherited Metabolic Disease.

Prediction of disease severity in multiple acyl‐CoA dehydrogenase deficiency: A retrospective and laboratory cohort study

S. Ferdinandusse, R. Wanders, T. Derks, 2019, Journal of inherited metabolic disease.

A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms (“KHENERGYC”)

J. Smeitink, L. de Boer, H. Renkema, 2022, BMC Neurology.

Psychosocial, cognitive, and motor functioning in patients with suspected Sotos syndrome: a comparison between patients with and without NSD1 gene alterations.

J. Wit, L. de Boer, L. Boer, 2006, Developmental medicine and child neurology.